Predictive Ability of Charlson Comorbidity Index on Outcomes From Lung Cancer
- 1 December 2011
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 34 (6) , 593-596
Abstract
Background The effect of age and/or comorbidities on management decisions in lung cancer patients has been debated. The Charlson Comorbidity Index (CCI) was developed to help predict mortality from chronic medical conditions. This study was undertaken to evaluate whether CCI is correlated with survival in lung cancer. Patients and Methods A retrospective chart review of 617 lung cancer patients diagnosed between 1994 and 2007 was conducted. CCI was calculated for each patient with and without the inclusion of age. Multivariate Cox proportional hazard regression analysis was used to evaluate the relationship between CCI and survival while adjusting for other prognostic factors. Results Six patients were excluded from the final analysis due to missing outcome or comorbidity data. The median age at diagnosis was 64 years (range, 16-89 y). Five hundred fourteen patients (84%) had nonsmall cell lung cancer and 97 patients (16%) had small cell lung cancer. Using multivariate analysis, no correlation was found between CCI and risk of death whether or not age was included in the index score. Conclusions CCI did not provide predictive validity for survival of lung cancer patients. Development of accurate and predictive prognostic models to help estimate a patient's prognosis is needed.Keywords
This publication has 22 references indexed in Scilit:
- Therapeutic options for elderly patients with advanced non-small cell lung cancerCancer Treatment Reviews, 2009
- Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Characteristics of patients with lung cancer under the age of 45 years: A case control studyRespirology, 2001
- Comorbidity and functional status are independent in older cancer patients.Journal of Clinical Oncology, 1998
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- The effect of age on treatment choice and survival in elderly breast cancer patientsCancer, 1991
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Applying results of randomised trials to clinical practice: impact of losses before randomisation.BMJ, 1984
- Controversy in Counting and Attributing Events in Clinical TrialsNew England Journal of Medicine, 1979